Malignant Neck Neoplasm — Trials

Malignant Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 607
Recruiting: 330
Ph III recruiting: 76
Growth YoY: +6.3%
Industry share: 10%
Top sponsor: Sun Yat-sen University
Termination share: 27.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (181)

clinicaltrialsPublishedShowing 151–200 of 2,145 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02657551	A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer	completed	Phase 2	17	Dana-Farber Cancer InstituteOTHER	1	Aug 12, 2026	clinicaltrials
NCT04609280	Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110)(SAVER)	active not recruiting	Phase 2	52	University of Maryland, BaltimoreOTHER	1	Aug 12, 2026	clinicaltrials